ストックスクリーナーアプリを入手
5.72
0.53%
0.03
アフターアワーズ：
5.70
-0.02
-0.35%
前日終値:
$5.69
開ける：
$5.78
24時間の取引高:
1.92M
Relative Volume:
0.76
時価総額：
$929.54M
収益：
-
当期純損益:
$-206.69M
株価収益率:
-4.2198
EPS:
-1.3555
ネットキャッシュフロー:
$-186.49M
1週間 パフォーマンス:
-4.67%
1か月 パフォーマンス:
+4.00%
6か月 パフォーマンス:
+90.03%
1年 パフォーマンス:
+216.02%
1日の値動き範囲:
$5.635
$5.88
1週間の範囲:
$5.62
$6.065
52週間の値動き範囲:
$1.60
$7.18
Annexon Inc Stock (ANNX) Company Profile
Compare ANNX vs VRTX, REGN, ARGX, ALNY, ONC
| 株式 | 価格 | 時価総額 | 収益 | 当期純利益 | 現金流量 | EPS |
|---|---|---|---|---|---|---|
ANNX
Annexon Inc
|
5.72 | 924.67M | 0 | -206.69M | -186.49M | -1.3555 |
VRTX
Vertex Pharmaceuticals Inc
|
424.36 | 109.34B | 12.32B | 4.34B | 3.19B | 16.86 |
REGN
Regeneron Pharmaceuticals Inc
|
702.27 | 74.35B | 14.92B | 4.42B | 3.79B | 41.04 |
ARGX
Argen X Se Adr
|
794.70 | 50.44B | 4.16B | 1.29B | 734.26M | 19.58 |
ALNY
Alnylam Pharmaceuticals Inc
|
301.11 | 39.78B | 3.71B | 313.75M | 465.38M | 2.2571 |
ONC
Beone Medicines Ltd Adr
|
297.49 | 33.02B | 5.36B | 287.73M | 924.18M | 2.5229 |
Annexon Inc Stock (ANNX) Upgrades & Downgrades
| 日付 | アクション | アナリスト | 評価の変更 |
|---|---|---|---|
| 2025-12-23 | 開始されました | Chardan Capital Markets | Buy |
| 2024-03-01 | アップグレード | JP Morgan | Neutral → Overweight |
| 2023-12-21 | アップグレード | BofA Securities | Neutral → Buy |
| 2023-10-30 | 開始されました | Wells Fargo | Overweight |
| 2023-05-26 | ダウングレード | BofA Securities | Buy → Neutral |
| 2023-05-25 | ダウングレード | JP Morgan | Overweight → Neutral |
| 2022-09-16 | 開始されました | Jefferies | Buy |
| 2022-09-09 | 開始されました | BTIG Research | Buy |
| 2021-11-30 | 開始されました | H.C. Wainwright | Buy |
| 2021-09-23 | 開始されました | Cantor Fitzgerald | Overweight |
| 2021-01-26 | 開始されました | Needham | Buy |
| 2020-08-18 | 開始されました | BofA Securities | Buy |
| 2020-08-18 | 開始されました | Cowen | Outperform |
| 2020-08-18 | 開始されました | JP Morgan | Overweight |
すべてを表示
Annexon Inc (ANNX) 最新ニュース
ANNX Earnings History & Surprises | EPS & Revenue Results | ANNEXON INC (NASDAQ:ANNX) - ChartMill
Wall Street analysts see a 165.52% upside in Annexon (ANNX): Can the stock really move this high? - MSN
Annexon | DEFA14A: Others - Moomoo
Annexon | ARS: Annual Report to Security Holders - Moomoo
ANNX: Late-stage C1q inhibitors show strong efficacy in GBS and GA, with pivotal data due in 2026 - TradingView
Annexon (NASDAQ: ANNX) proxy asks approval to boost share authorization and elect directors - Stock Titan
Annexon stock rises after director purchases shares - MSN
Annexon presents four studies on Guillain-Barre syndrome disease burden and targeted therapies - Traders Union
Annexon (ANNX): 7 Small Cap Stocks with the Highest Upside Potential - Insider Monkey
Annexon Biosciences Stock Surges 289 Percent Amid Clinical Progress - HarianBasis.co
Annexon Biosciences (ANNX) Buy Rating Retained - Insider Monkey
Annexon, Inc. (NASDAQ:ANNX) Given Average Recommendation of "Moderate Buy" by Brokerages - MarketBeat
Does Annexon’s 2026 “Win Year” Milestone Roadmap Reshape The Bull Case For Annexon (ANNX)? - simplywall.st
Analysts Offer Insights on Healthcare Companies: Danaher (DHR), Annexon Biosciences (ANNX) and UnitedHealth (UNH) - The Globe and Mail
Annexon (NASDAQ: ANNX) seeks vote to increase authorized shares to 500M - Stock Titan
Needham Maintains Annexon(ANNX.US) With Buy Rating, Maintains Target Price $11 - Moomoo
Annexon | PRE 14A: Preliminary proxy statements relating to merger or acquisition - Moomoo
Annexon CEO Touts “Win Year” 2026 at Needham, Eyes GA Phase III Data and GBS FDA Filing - Yahoo Finance
Annexon (NASDAQ:ANNX) Trading 8.5% Higher Following Insider Buying Activity - MarketBeat
Carson buys $49k in Annexon (ANNX) stock - Investing.com
Insider Buying: Annexon (NASDAQ:ANNX) Director Purchases 8,000 Shares of Stock - MarketBeat
Carson buys $49k in Annexon (ANNX) stock By Investing.com - Investing.com India
Annexon (NASDAQ: ANNX) director adds 8,000 shares in planned stock purchase - Stock Titan
EV Market: Will Annexon Inc benefit from government policyWall Street Watch & Technical Buy Zone Confirmation - baoquankhu1.vn
Annexon (NASDAQ:ANNX) Shares Down 6.1%Here's Why - MarketBeat
Is Annexon (ANNX) Stock Undervalued Now | ANNX Q4 Earnings: Beats Estimates by $0.04PEG Ratio - Cổng thông tin điện tử tỉnh Lào Cai
Macro Review: Will Annexon Inc benefit from government policyPortfolio Gains Summary & Real-Time Volume Analysis Alerts - baoquankhu1.vn
Annexon to Present at the 25th Annual Needham Virtual Healthcare Conference - Bitget
Geopolitics Watch: What are the risks of holding Annexon Inc2026 Analyst Calls & Long-Term Investment Growth Plans - baoquankhu1.vn
Annexon (NASDAQ:ANNX) Shares Up 6.6%What's Next? - MarketBeat
HC Wainwright Estimates Annexon FY2030 Earnings - MarketBeat
Annexon posts full-year 2025 financial results and portfolio updates - Traders Union
Annexon Inc (ANNX) 財務データ
収益
当期純利益
現金流量
EPS
0.14%
0.48%
大文字化:
|
ボリューム (24 時間):